Clinical Trial Update: Betaferon® Regulatory Post-Marketing Surveillance

View source ↗

Summary

A completed regulatory post-marketing surveillance trial for Betaferon (interferon beta-1b) assessing safety in multiple sclerosis and clinically isolated syndr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clinically Isolated Syndrome
• Multiple Sclerosis

Drugs mentioned

• Betaferon (interferon beta-1b)

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis, Clinically Isolated System | Status: COMPLETED